Topics

Articles

Ways to reimagine pharma’s operating model and KPIs for commercial success in an AI-driven future.

Measuring What Matters

Videos

Blake Powers, CEO, medigi, explains how digital tools, AI, and automation are streamlining access to biosimilars and cell and gene therapies, signaling a shift toward more tech-enabled, patient-centric care.

Asembia 2025: Digital Health and Biosimilars Shape the Future of Pharmacy

Chip Parkinson, CEO, GiftHealth, explains how AI-powered data integration is bringing new hope to patients by revealing hidden access barriers, streamlining treatment pathways, and challenging outdated utilization management practices.

Asembia 2025: Why AI Could Be the Key to Solving Access Challenges in Healthcare

Doug Long, VP, industry relations, IQVIA, examines shifting pharmaceutical trends, including specialty growth, biosimilar gaps, reimbursement pressure from GLP-1s, and persistent access challenges.

Asembia 2025: Rare Disease Therapies Drive Shift in Drug Development Focus

Podcasts

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework. 

Fast-Tracking the Future

By embracing practical, human-centered use cases, life sciences companies are breaking free from GenAI “pilotitis” and demonstrating how scalable AI solutions can help transform patient care and provider efficiency.

Innovation with GenAI: Lessons from Life Sciences and Beyond

Director of Project Services & Logistics at Almac Pharma Services.

Exploring the importance of contract development and manufacturing organizations in advancing the latest technology for effective delivery of temperature-sensitive medicines.

The Role of CDMOs in the Pharma Cold Chain Machine

Steffen Lang, president, operations, executive committee member, Novartis, discusses what to expect from Novartis over the next decade in terms of technological innovations. 

LogiPharma Europe 2025: Driving Innovation in Core Therapeutic Areas

How can stakeholders prepare for changing therapy requirements?  

LogiPharma Europe 2025: Reevaluating One’s CGT Value Chain

A keynote presentation describes how supply chain visibility should rely on digital capabilities. 

Data & Technology